General form of registration statement for all companies including face-amount certificate companies

Stock-Based Compensation (Tables)

v3.22.2.2
Stock-Based Compensation (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]    
Summary of stock option activity under the Plan
Stock option activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):
 
 
  
Options Outstanding
 
 
  
Number of
Options
 
  
Weighted-
Average
Exercise Price
 
  
Weighted-
Average
Remaining
Contractual
Life (years)
 
  
Aggregate
Intrinsic Value
 
Balance – December 31, 2021
     23,708,957      $ 3.05        7.99      $ 125,429  
Recapitalization
     4,173,563        (0.46                
 
Balance – December 31, 2021
     27,882,520        2.59        7.99        125,429
 
Exercised
     (205,337      1.60                    
Cancelled/forfeited
     (3,041,496      3.44                    
    
 
 
                            
Balance – June 30, 2022
     24,635,687        2.53        7.42        54,818  
    
 
 
                            
Options vested and exercisable – June 30, 2022
     15,742,548      $ 1.81        6.87      $ 44,349  
    
 
 
                            
Stock option activity under the Plan is as follows (in thousands, except share and per share amounts):
 
 
  
Options Outstanding
 
 
  
Number of

Options
 
  
Weighted–

Average
Exercise
Price
 
  
Weighted-
Average
Remaining
Contractual
Life (years)
 
  
Aggregate
Intrinsic Value
 
Balance – December 31, 2020
     18,733,170      $ 1.48        8.15      $ 52,909  
Granted
     11,669,107        4.32                    
Exercised
     (760,548      1.41                    
Forfeited and expired
     (1,759,209      2.67                    
    
 
 
                            
Balance – December 31, 2021
     27,882,520        2.59        7.99      $ 125,429  
    
 
 
                            
Options vested and exercisable – December 31, 2021
     13,374,892      $ 1.56        7.16      $ 73,885  
    
 
 
                            
Schedule of nonvested performance-based units activity
Performance-based restricted stock units activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):
 
 
  
Number

of shares
 
  
Weighted-
Average Grant
Date Fair Value
Per Share
 
Unvested – December 31, 2021
  
 
1,511,191
 
  
$
8.62
 
Recapitalization
  
 
265,992
 
  
 
(1.29
Unvested – December 31, 2021
  
 
1,777,183
 
  
 
7.33
 
Granted
  
 
4,748,063
 
  
 
6.98
 
Vested
  
 
(593,971
  
 
6.93
 
Cancelled/forfeited
  
 
(823,880
  
 
6.71
 
 
  
 
 
 
  
     
Balance – June 30, 2022
  
 
5,107,395
 
  
 
6.71
 
 
  
 
 
 
  
     
Vested but unissued – June 30, 2022
  
 
593,971
 
  
$
6.93
 
 
  
 
 
 
  
     
 
Summary of the restricted common stock   A summary of the restricted common stock is as follows:
Schedule of share-based payment award, stock options, valuation assumptions
The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:
 
 
  
Six Months Ended June 30,
 
  
2021
Fair value of common stock
 
$5.06 – $6.45
Expected term (in years)
 
5.00 – 6.28
Volatility
 
62.33% – 75.19%
Risk-free interest rate
 
0.50% – 1.16%
Dividend yield
 
The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:
 
    
Year Ended December 31,
    
2019
  
2020
  
2021
Fair value of common stock
   $2.90 – 3.27    $2.96 – 3.53    $5.06 – 7.28
Expected term (in years)
   5.00 – 6.11    5.00 – 6.11    5.00 – 6.28
Volatility
   58.49% – 59.39%    61.12% – 74.34%    62.33% – 75.19%
Risk-free interest rate
   1.72% – 1.98%    0.21% – 1.66%    0.50% – 1.21%
Dividend yield
   —  %    —  %    —  %
Schedule of Restricted Common Stock A summary of the restricted common stock is as follows:
 
 
Number of
Options
 
 
Weighted-
Average
Exercise Price
 
Outstanding and unvested as of December 31, 2021
 
 
69,513
 
 
$
2.25
 
Recapitalization
 
 
12,237
 
 
 
(0.33
Outstanding and unvested as of December 31, 2021
 
 
81,750
 
 
 
1.92
 
Vested
 
 
(65,211
 
 
1.92
 
Repurchase of early exercise
 
 
(16,539
 
 
1.92
 
 
 
 
 
 
 
 
 
 
Outstanding and unvested as of June 30, 2022
 
 
—  
 
 
$
—